1. Home
  2. HCWB vs TLIH Comparison

HCWB vs TLIH Comparison

Compare HCWB & TLIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HCWB

HCW Biologics Inc.

HOLD

Current Price

$3.26

Market Cap

14.8M

Sector

Health Care

ML Signal

HOLD

TLIH

Ten-League International Holdings Limited Ordinary Shares

HOLD

Current Price

$5.72

Market Cap

12.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
HCWB
TLIH
Founded
2018
1998
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.8M
12.9M
IPO Year
2021
2023

Fundamental Metrics

Financial Performance
Metric
HCWB
TLIH
Price
$3.26
$5.72
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$35.00
N/A
AVG Volume (30 Days)
61.4K
5.5K
Earning Date
05-15-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.37
N/A
Revenue
$4,099,750.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$9.14
$3.34
Revenue Growth
N/A
N/A
52 Week Low
$0.25
$0.22
52 Week High
$7.35
$5.96

Technical Indicators

Market Signals
Indicator
HCWB
TLIH
Relative Strength Index (RSI) 52.15 63.98
Support Level $0.37 $0.30
Resistance Level $4.00 $5.93
Average True Range (ATR) 0.44 0.25
MACD -0.03 -0.06
Stochastic Oscillator 50.53 85.29

Price Performance

Historical Comparison
HCWB
TLIH

About HCWB HCW Biologics Inc.

HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.

About TLIH Ten-League International Holdings Limited Ordinary Shares

Ten-League International Holdings Ltd is a Singapore-based provider of turnkey project solutions. Its business consists of sales of heavy equipment and parts, heavy equipment rental, and provision of engineering consultancy services to port, construction, civil engineering, and underground foundation industries. It currently conducts its operations through its wholly-owned subsidiaries. The equipment it provides is organized into four categories based on their functions and application scenarios, namely, foundation equipment, hoist equipment, excavation equipment, and port machinery. The company operates in Singapore and Other international countries.

Share on Social Networks: